Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Effect of orally administered Lactobacillus brevis HY7401 in a food allergy mouse model.

  • 2013-11
  • Journal of Microbiology and Biotechnology 23(11)
    • Jeongmin Lee
    • Jieun Bang
    • H. Woo

Abstract

We had found that orally administered Lactobacillus species were effective immune modulators in ovalbumin (OVA)-sensitized mice. To validate these findings, we investigated the effects of orally administered Lactobacillus brevis HY7401 in OVA-T cell receptor transgenic mice. This strain showed a tendency to induce Th1 cytokines and inhibit Th2 cytokines. All assayed isotypes of OVA-specific antibody were effectively reduced. Systemic anaphylaxis was also relatively reduced with the probiotic administration. These results reveal that L. brevis HY7401 might be useful to promote anti-allergic processes through oral administration.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevisReduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevisReduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevisReduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis HA-112Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis HA-112Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis LB01Reduced Allergic ResponsesBeneficial
Moderate
Lactobacillus brevis LB01Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis LB01Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis LB01Reduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis Lbr-35Induced Th1 CytokinesBeneficial
Moderate
Lactobacillus brevis Lbr-35Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis Lbr-35Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis Lbr-35Reduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced Allergic ResponsesBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis MAK11L82BReduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis MAK11L82BReduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis SBC8803Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis SBC8803Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis SBC8803Reduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis SD-5214Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis SD-5214Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis SD-5214Reduced Th2 Cytokine LevelsBeneficial
Moderate
Lactobacillus brevis UALbr-02Reduced OVA-Specific AntibodiesBeneficial
Large
Lactobacillus brevis UALbr-02Reduced Systemic AnaphylaxisBeneficial
Moderate
Lactobacillus brevis VPro 18Increased Th1 Cytokine ProductionBeneficial
Moderate
Lactobacillus brevis VPro 18Reduced Th2 Cytokine ProductionBeneficial
Moderate
Back to top